+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Japan-Europe

  • ID: 4861798
  • Report
  • September 2019
  • Region: Global
  • 68 pages
  • FinGlobe, Inc

FEATURED COMPANIES

  • ADL Bionatur Solutions SA
  • Biofrontera AG
  • Eisai Co. Ltd.
  • Lonza Pharma & Biotech
  • Olympus Corporation
  • Shionogi & Co. Ltd.
  • MORE
This trends report provides comprehensive analysis on all licensing deals and negotiations that took place between the healthcare companies of Japan and Europe during January 1, 2019 to August 31, 2019, categorized and summarized by various important aspects such as key countries, healthcare sub-sectors, market capitalization groups, medicine groups, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of Japan and Europe.

Analytical data coverage:
  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 50+ healthcare licensing news between Japanese (34) and European (46) companies
  • Small-mid-large cap companies covered - LargeCap (29%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered - Pharmaceuticals (39%), Biotech (26%), Medical Devices (17%), Healthcare Services (14%)
  • 14 medicine groups studied - Oncology (33%), Gastroenterology (14%), Pulmonology (8%)
  • 8+ variables analyzed
Key Features:
  • 8 months’ healthcare licensing transactions between Japan and Europe analyzed at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized
The Report is useful to:
  • Japanese and European healthcare companies planning to introduce products in each other’s markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals between Japanese and European companies
  • Investors analyzing varied kinds of transaction options for licensing deals between Japan and Europe
Key analysis provided: January-August 2019
  • Total number of licensing deals signed between the companies of Japan and Europe
  • Total number of companies/institutes of Japan and Europe involved in the licensing deals
  • Most licensing deals signed by which European country’s companies with Japan
  • Most licensing deals signed by which country’s companies
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ADL Bionatur Solutions SA
  • Biofrontera AG
  • Eisai Co. Ltd.
  • Lonza Pharma & Biotech
  • Olympus Corporation
  • Shionogi & Co. Ltd.
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions between Japan and Europe licensed during last eight months
1.1 Companies with most licensing deals for Japan and Europe
1.2 Healthcare sub-sectors with most licensing deals
1.3 Market capitalization groups with most licensing deals
1.4 Medicine groups most active in licensing deals
1.5 Licensing payment arrangements most followed
1.6 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals between Japan and Europe by key attributes during last eight months
2.1 For each of the key countries
2.2 For each of the healthcare sub-sectors
2.3 For each of the marketcap groups
2.4 For each of the medicine groups

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed between Japan and Europe during last eight months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By country and company name
Appendix 6 List of not-for-profit groups covered - By country and institute name
Appendix 7 List of companies/institutes covered - By medicine group and company name
Appendix 8 List of companies/institutes covered - By terms of payment and company name
Appendix 9 Licensing deals discontinued between Japan and Europe during last eight months
Note: Product cover images may vary from those shown
  • Adaptimmune Therapeutics plc
  • ADL Bionatur Solutions SA
  • Aeon International Co., Ltd
  • Alvotech
  • AMR Centre Ltd.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Batavia Biosciences BV
  • Bayer AG
  • BioArctic AB
  • Biocartis Group NV
  • Biofrontera AG
  • BioInvent International AB
  • Cancer Research UK
  • Cantargia AB
  • Chiome Bioscience Inc.
  • Coalition for Epidemic Preparedness Innovations
  • Cosmo Pharmaceuticals N.V.
  • Crescendo Biologics Ltd.
  • CYBERDYNE, INC.
  • Daiichi Sankyo Co. Ltd.
  • Dr. Falk Pharma GmbH
  • EA Pharma Co., Ltd
  • Eisai Co. Ltd.
  • ExpreS2ion Biotech Holding AB
  • Ferring Holding SA
  • Fuji Pharma Co Ltd
  • Fujifilm Corporation
  • FUJIFILM Wako Pure Chemical Corporation
  • Genovis AB
  • Grupo Ferrer Internacional, S.A.
  • Hubrecht Organoid Technology
  • Inspirata Europe, Ltd.
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
  • Joimax GmbH
  • Kyoto University
  • Kyowa Hakko Kirin Co. Ltd.
  • L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A.
  • LifeArc®
  • Lonza Pharma & Biotech
  • Maruho Co., Ltd.
  • medac GmbH
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corporation
  • National Cancer Center Japan (The)
  • National Centre for the Replacement, Refinement & Reduction of Animals in Research
  • NEC Corporation
  • Nichirei Bioscience Inc
  • Noile-Immune Biotech Inc.
  • Novartis AG
  • NTC Srl
  • Olympus Corporation
  • Ono Pharmaceutical Co., Ltd.
  • OptiBiotix Health PLC
  • Oxford BioMedica plc
  • PeptiDream Inc.
  • PledPharma AB
  • Primetech Corporation
  • Qaelum NV
  • QIAGEN N.V.
  • Rigaku Corporation
  • Sandoz Pharmaceuticals GmbH
  • Santen Pharmaceutical Co., Ltd.
  • Shionogi & Co. Ltd.
  • Solasia Pharma K.K.
  • Sosei Group Corporation
  • Takeda Pharmaceutical Company Limited
  • Tenshindo Co., Ltd.
  • Toyo Business Engineering Corporation
  • Toyo Corporation
  • Transgene SA
  • United Biomech Japan, Inc.
  • University of Dundee
  • University of Tokyo
  • Vect-Horus S.A.S.
  • Vectura Group plc
  • Velabs Therapeutics GmbH
  • Vitrolife AB
  • Werum IT Solutions GmbH
  • Yamaha Motor Company Limited
Note: Product cover images may vary from those shown
Adroll
adroll